Recombinant Domain of Flagellin Promotes In Vitro a Chemotactic Inflammatory Profile in Human Immune Cells Independently of a Dendritic Cell Phenotype

Molecules. 2023 Mar 5;28(5):2394. doi: 10.3390/molecules28052394.

Abstract

Flagellin is the major component of the flagellum in gram-positive and -negative bacteria and is also the ligand for the Toll-like receptor 5 (TLR5). The activation of TLR5 promotes the expression of proinflammatory cytokines and chemokines and the subsequent activation of T cells. This study evaluated a recombinant domain from the amino-terminus D1 domain (rND1) of flagellin from Vibrio anguillarum, a fish pathogen, as an immunomodulator in human peripheral blood mononuclear cells (PBMCs) and monocyte-derived dendritic cells (MoDCs). We demonstrated that rND1 induced an upregulation of proinflammatory cytokines in PBMCs, characterized at the transcriptional level by an expression peak of 220-fold for IL-1β, 20-fold for IL-8, and 65-fold for TNF-α. In addition, at the protein level, 29 cytokines and chemokines were evaluated in the supernatant and were correlated with a chemotactic signature. MoDCs treated with rND1 showed low levels of co-stimulatory and HLA-DR molecules and kept an immature phenotype with a decreased phagocytosis of dextran. We probed that rND1 from a non-human pathogen promotes modulation in human cells, and it may be considered for further studies in adjuvant therapies based on pathogen-associated patterns (PAMPs).

Keywords: PAMPs; TLR5; cytokines; flagellin; immunomodulation.

MeSH terms

  • Chemokines / metabolism
  • Chemotaxis, Leukocyte*
  • Cytokines / metabolism
  • Dendritic Cells
  • Flagellin* / genetics
  • Flagellin* / pharmacology
  • Humans
  • Leukocytes, Mononuclear / metabolism
  • Phenotype
  • Toll-Like Receptor 5 / genetics
  • Toll-Like Receptor 5 / metabolism
  • rho GTP-Binding Proteins / metabolism

Substances

  • Chemokines
  • Cytokines
  • Flagellin
  • rho GTP-Binding Proteins
  • RND1 protein, human
  • Toll-Like Receptor 5

Grants and funding